人工泪液微生物生长动力学的体外研究
配方解释了57%的AUC变异,超过菌株层面的9%。
要点
- 无防腐剂人工泪液较含防腐剂配方显著促进微生物增殖(P < .001)。
- 无防腐剂单剂量瓶中铜绿假单胞菌曲线下面积最高,生长延迟但更强。
- 含防腐剂人工泪液杀菌活性一致,不依赖防腐剂类型。
核心结论
- 人工泪液中微生物增殖高度依赖配方,无防腐剂配方污染风险最大,含防腐剂配方提供广谱抑制。
主要发现
- 无防腐剂人工泪液在所有菌种中支持显著多于含防腐剂配方的微生物增殖(P < .001)。
- 无防腐剂单剂量瓶曲线下面积最高,铜绿假单胞菌显示延迟但更稳健的生长。
- 含防腐剂人工泪液杀菌活性一致,无防腐剂配方主要为抑菌或允许生长。
- 线性混合效应模型显示配方解释57%的AUC变异,超过菌株层面的9%。
临床怎么用
- 选择人工泪液时应考虑配方对微生物污染风险的影响,无防腐剂单剂量瓶风险最高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Artificial tears (ATs) are widely used to relieve ocular symptoms of irritation, yet their diverse formulations containing varying viscosity agents, electrolytes, osmoprotectants, oils, and surfactants may differentially support microbial growth. This study compared the growth of Staphylococcus aureus and Pseudomonas aeruginosa in commercially available ATs to identify formulation-dependent differences in susceptibility to contamination. DESIGN: Laboratory investigation. METHODS: Clinical and reference isolates of methicillin-sensitive S. aureus (MSSA), methicillin-resistant S. aureus (MRSA), and P. aeruginosa were recovered from patient sources (conjunctiva [n = 2], contact lens [n = 1], cornea [n = 5], corneal button [n = 1], eyelids [n = 6], lacrimal sac [n = 2], and sclera [n = 1]) and inoculated into ten ATs categorized as preservative-containing multidose bottles (MDBs), preservative-free (PF)- MDBs, or PF single-dose vials (SDVs). Turbidity of the samples was recorded for 24 hours and growth kinetics, lag time (λ), specific growth rate (µ), and area under the curve (AUC), were derived using the Gompertz equation. Samples were cultured to quantify microbial growth. MAIN OUTCOME: Microbial growth. RESULTS: PF ATs supported significantly greater microbial proliferation than preserved formulations across all organisms (P < .001). Among PF ATs, SDVs exhibited the highest AUCs, particularly for P. aeruginosa, which showed delayed but more robust growth compared with S. aureus strains. Preserved ATs demonstrated uniform bactericidal activity irrespective of preservative type, whereas PF formulations were largely bacteriostatic or permissive to growth. Linear mixed-effects modeling indicated that AT formulation explained most AUC variability (57%), exceeding strain-level effects (9%). CONCLUSIONS: Microbial proliferation in ATs is strongly formulation dependent. PF formulations pose the greatest contamination risk, whereas preserved ATs provide broad-spectrum inhibition. These findings emphasize the need for formulation-specific evaluation of ATs and future optimization strategies that balance antimicrobial protection with ocular surface safety.
引用
- Tribin FE, Durkee H, Alfonso A, et al. In Vitro Study of Microbial Growth in Artificial Tears Using a Novel Kinetic and Culture-Based Model. Am J Ophthalmol. 2026. PMID: 41956347. doi:10.1016/j.ajo.2026.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。